Herbas VPB

Print
EN | LT
LT - PHOSPHORYLATED C-ERBB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER
EN - PHOSPHORYLATED C-ERBB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/574
European patent
(11) Number of the document 2313780
(13) Kind of document T
(96) European patent application number 09790143.3
Date of filing the European patent application 2009-07-08
(97) Date of publication of the European application 2011-04-27
(45) Date of publication and mention of the grant of the patent 2015-05-20
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2009/049903
Date 2009-07-08
PCT application publication
(87) Number WO 2010/006027
Date 2010-01-14
Priority applications
(30) Number Date Country code
78956 P 2008-07-08 US
Inventors
(72)
PETRICOIN, Emanuel, III, US
LIOTTA, Lance, US
ESPINA, Virginia, US
WULFKUHLE, Julia, US
Grantee
(73) George Mason Research Foundation, Inc., 4400 University Drive, Fairfax, VA 22030, US
Title
(54) PHOSPHORYLATED C-ERBB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER
  PHOSPHORYLATED C-ERBB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER
Last update date 2021-04-30